United Therapeutics (UTHR) Leases (2022)

United Therapeutics' (UTHR) quarterly Leases came in at $12.2 million in Q3 2022.

United Therapeutics (UTHR) Leases (2022) Analysis & Trends

United Therapeutics has disclosed Leases across 1 years of filings, most recently posting $12.2 million for Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Leases (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	335.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	282.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	447.10 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	78.25 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	144.25 Mn
10	Liquidia	5.63 Bn	5.40 Bn	121.79 Mn	4.36 Mn

Download Data

Date	Value
Sep 30, 2022	12.20 Mn